Cargando…
Patients’ health literacy in psychotic disorders
Compliance and relapse are major issues in the treatment of psychotic disorders. About 50% of subjects with schizophrenia do not comply with treatment and relapse rates of 65% are reported after one year and 80% after two years. Drug treatments are effective against psychotic symptoms, but cannot pr...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655084/ https://www.ncbi.nlm.nih.gov/pubmed/19300580 |
_version_ | 1782165434960707584 |
---|---|
author | Saba, Ghassen Mékaoui, Lila Leboyer, Marion Schürhoff, Franck |
author_facet | Saba, Ghassen Mékaoui, Lila Leboyer, Marion Schürhoff, Franck |
author_sort | Saba, Ghassen |
collection | PubMed |
description | Compliance and relapse are major issues in the treatment of psychotic disorders. About 50% of subjects with schizophrenia do not comply with treatment and relapse rates of 65% are reported after one year and 80% after two years. Drug treatments are effective against psychotic symptoms, but cannot promote functional recovery or prevent relapses when prescribed alone. The factors influencing compliance include side effects and the patients’ awareness of their illness. Psychosocial interventions, cognitive remediation and psychotherapy have been proposed as adjuvant treatments to increase compliance and to decrease the rate of relapse. Most of these interventions have been shown to increase compliance and to decrease the rate of relapse, but the most robust results have been achieved with cognitive behavioral therapy. |
format | Text |
id | pubmed-2655084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26550842009-03-19 Patients’ health literacy in psychotic disorders Saba, Ghassen Mékaoui, Lila Leboyer, Marion Schürhoff, Franck Neuropsychiatr Dis Treat Original Research Compliance and relapse are major issues in the treatment of psychotic disorders. About 50% of subjects with schizophrenia do not comply with treatment and relapse rates of 65% are reported after one year and 80% after two years. Drug treatments are effective against psychotic symptoms, but cannot promote functional recovery or prevent relapses when prescribed alone. The factors influencing compliance include side effects and the patients’ awareness of their illness. Psychosocial interventions, cognitive remediation and psychotherapy have been proposed as adjuvant treatments to increase compliance and to decrease the rate of relapse. Most of these interventions have been shown to increase compliance and to decrease the rate of relapse, but the most robust results have been achieved with cognitive behavioral therapy. Dove Medical Press 2007-08 /pmc/articles/PMC2655084/ /pubmed/19300580 Text en © 2007 Dove Medical Press Limited. All rights reserved |
spellingShingle | Original Research Saba, Ghassen Mékaoui, Lila Leboyer, Marion Schürhoff, Franck Patients’ health literacy in psychotic disorders |
title | Patients’ health literacy in psychotic disorders |
title_full | Patients’ health literacy in psychotic disorders |
title_fullStr | Patients’ health literacy in psychotic disorders |
title_full_unstemmed | Patients’ health literacy in psychotic disorders |
title_short | Patients’ health literacy in psychotic disorders |
title_sort | patients’ health literacy in psychotic disorders |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655084/ https://www.ncbi.nlm.nih.gov/pubmed/19300580 |
work_keys_str_mv | AT sabaghassen patientshealthliteracyinpsychoticdisorders AT mekaouilila patientshealthliteracyinpsychoticdisorders AT leboyermarion patientshealthliteracyinpsychoticdisorders AT schurhofffranck patientshealthliteracyinpsychoticdisorders |